“Ebstein's Anomaly” a potential cause of misinterpretation on myocardial perfusion imaging
Komal Bishnoi, Girish Kumar Parida, Ralph Emerson, Kanhaiyalal Agrawal
Department of Nuclear Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
Correspondence Address:
Dr. Girish Kumar Parida
Department of Nuclear Medicine, All India Institute of Medical Sciences, Bhubaneswar - 751 019, Odisha
India
Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ijnm.ijnm_43_22
Ebstein's anomaly is a rare congenital heart disease. We present the case of a 47-year-old woman with history of Ebstein's anomaly who was referred to nuclear medicine department for a myocardial perfusion single-photon emission computed tomography (SPECT) imaging during pre-anesthetic check-up. Myocardial SPECT perfusion images with (99mTc)-Sestamibi demonstrated medium sizes fixed perfusion defect in the mid and proximal infero-septal wall adjacent inferior wall. This is a cause of potential misinterpretation on myocardial SPECT perfusion imaging as this perfusion defect was due to fibrosis rather than scarred myocardium.
Keywords: (99mTc)-Sestamibi, Ebstein's anomaly, myocardial single-photon emission computed tomography perfusion imaging
A 47-year-old woman with a known history of Ebstein's anomaly, was referred for myocardial perfusion imaging to our department during her preanesthetic checkup. She was supposed to undergo surgery for carcinoma stomach. The transesophageal echocardiography revealed dilated right ventricle with a 3 cm. Ostium secundum atrial septal defect. There was no pulmonary artery hypertension with a normal pulmonary venous return. The left ventricular function was preserved. A myocardial perfusion single-photon emission computed tomography (SPECT) with a 1-day protocol was performed (stress/rest [99mTc]-Sestamibi). The pharmacological stress test was performed with adenosine infusion for 6 min, with no significant electrocardiogram changes. 10 mCi and 25 mCi of radiotracer was injected during the stress and rest part of the study, respectively. SPECT perfusion images demonstrated a medium-sized fixed perfusion defect in the mid and proximal and mid-inferoseptal wall and adjacent inferior wall [Figure 1]. In addition, the right heart chambers appeared enlarged. To confirm the perfusion defect, represents fibrosis rather than scarred myocardium, coronary angiography. The coronary angiography was found out to be normal. Ebstein's anomaly is a rare congenital heart disease.[1] It involves the tricuspid valve which is displaced downward toward apical portion of the heart.[2],[3] This causes atrialization of the right ventricle. There is ventricular hypoplasia and functional impairment. In newborns, it presents as cyanosis,[4],[5] whereas it may vary from arrhythmia to exertional dyspnea in adults. Ebstein's anomaly is one of the causes of the misdiagnosis of coronary artery disease. Adult patients with Ebstein's anomaly develop increased fibrosis in the left ventricular wall and basal and mid-septum.[6] This presents as left ventricular regional wall motion abnormalities.[7] This is in concordance with the findings of the myocardial perfusion scan in the described case, where the region with decreased counts represents the mid and proximal inferoseptal wall, which is fibrotic and therefore without (99mTc) uptake. The other explanation for the reduced septal perfusion in patients with Ebstein's anomaly could be the exaggerated motion of the septum or high attenuation caused by an enlarged right atrium leading to decreased counts from the septum.[8] Hence, it is imperative for nuclear medicine physicians to be aware of such uncommon but important artifacts while reporting myocardial perfusion scintigraphy.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Comments (0)